vs
Nutex Health, Inc.（NUTX）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
Ribbon Communications Inc.的季度营收约是Nutex Health, Inc.的1.1倍（$162.6M vs $151.7M），Ribbon Communications Inc.净利率更高（54.8% vs 7.8%，领先47.0%），Ribbon Communications Inc.同比增速更快（-10.3% vs -41.1%），过去两年Nutex Health, Inc.的营收复合增速更高（50.0% vs -8.1%）
Nutex Health是一家总部位于美国得克萨斯州休斯敦的营利性医疗企业，核心业务为运营各类医疗机构，是美国本土医疗领域的专业运营机构，致力于为当地市场提供相关医疗服务与场地运营支持。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
NUTX vs RBBN — 直观对比
营收规模更大
RBBN
是对方的1.1倍
$151.7M
营收增速更快
RBBN
高出30.8%
-41.1%
净利率更高
RBBN
高出47.0%
7.8%
两年增速更快
NUTX
近两年复合增速
-8.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $151.7M | $162.6M |
| 净利润 | $11.8M | $89.1M |
| 毛利率 | 30.4% | 42.9% |
| 营业利润率 | 20.4% | 37.6% |
| 净利率 | 7.8% | 54.8% |
| 营收同比 | -41.1% | -10.3% |
| 净利润同比 | -80.8% | — |
| 每股收益（稀释后） | $2.34 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NUTXRBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | $151.7M | $227.3M | ||
| Q3 25 | $267.8M | $215.4M | ||
| Q2 25 | $244.0M | $220.6M | ||
| Q1 25 | $211.8M | $181.3M | ||
| Q4 24 | $257.6M | $251.4M | ||
| Q3 24 | $78.8M | $210.2M | ||
| Q2 24 | $76.1M | $192.6M |
净利润NUTXRBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | $11.8M | — | ||
| Q3 25 | $55.4M | $-12.1M | ||
| Q2 25 | $-17.7M | $-11.1M | ||
| Q1 25 | $21.2M | $-26.2M | ||
| Q4 24 | $61.6M | — | ||
| Q3 24 | $-8.8M | $-13.4M | ||
| Q2 24 | $-364.0K | $-16.8M |
毛利率NUTXRBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | 30.4% | 53.3% | ||
| Q3 25 | 57.8% | 50.1% | ||
| Q2 25 | 51.2% | 49.6% | ||
| Q1 25 | 55.9% | 45.4% | ||
| Q4 24 | 55.0% | 55.7% | ||
| Q3 24 | 27.8% | 52.1% | ||
| Q2 24 | 29.7% | 50.8% |
营业利润率NUTXRBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | 20.4% | 4.1% | ||
| Q3 25 | 48.7% | 1.3% | ||
| Q2 25 | 13.8% | 1.9% | ||
| Q1 25 | 38.1% | -10.8% | ||
| Q4 24 | 44.4% | 13.2% | ||
| Q3 24 | 12.3% | -0.4% | ||
| Q2 24 | 7.0% | -1.0% |
净利率NUTXRBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | 7.8% | — | ||
| Q3 25 | 20.7% | -5.6% | ||
| Q2 25 | -7.3% | -5.0% | ||
| Q1 25 | 10.0% | -14.5% | ||
| Q4 24 | 23.9% | — | ||
| Q3 24 | -11.2% | -6.4% | ||
| Q2 24 | -0.5% | -8.7% |
每股收益（稀释后）NUTXRBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $2.34 | $0.50 | ||
| Q3 25 | $7.76 | $-0.07 | ||
| Q2 25 | $-2.95 | $-0.06 | ||
| Q1 25 | $3.33 | $-0.15 | ||
| Q4 24 | $11.56 | $0.05 | ||
| Q3 24 | $-1.72 | $-0.08 | ||
| Q2 24 | $-0.07 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $185.6M | $67.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $329.4M | $419.1M |
| 总资产 | $918.5M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NUTXRBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | $185.6M | $96.4M | ||
| Q3 25 | $166.0M | $74.8M | ||
| Q2 25 | $96.7M | $60.5M | ||
| Q1 25 | $84.7M | $71.2M | ||
| Q4 24 | $40.6M | $87.8M | ||
| Q3 24 | $46.9M | $37.2M | ||
| Q2 24 | $40.8M | $64.6M |
总债务NUTXRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | — | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
股东权益NUTXRBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | $329.4M | $449.0M | ||
| Q3 25 | $317.2M | $360.1M | ||
| Q2 25 | $235.3M | $370.4M | ||
| Q1 25 | $176.9M | $381.8M | ||
| Q4 24 | $132.4M | $404.6M | ||
| Q3 24 | $60.4M | $395.5M | ||
| Q2 24 | $62.7M | $405.0M |
总资产NUTXRBBN
| Q1 26 | — | — | ||
| Q4 25 | $918.5M | $1.2B | ||
| Q3 25 | $964.5M | $1.1B | ||
| Q2 25 | $841.0M | $1.1B | ||
| Q1 25 | $761.9M | $1.1B | ||
| Q4 24 | $655.3M | $1.2B | ||
| Q3 24 | $438.5M | $1.1B | ||
| Q2 24 | $422.4M | $1.1B |
负债/权益比NUTXRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $70.4M | — |
| 自由现金流经营现金流 - 资本支出 | $69.0M | — |
| 自由现金流率自由现金流/营收 | 45.5% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | 5.95× | — |
| 过去12个月自由现金流最近4个季度 | $245.6M | — |
8季度趋势，按日历期对齐
经营现金流NUTXRBBN
| Q1 26 | — | — | ||
| Q4 25 | $70.4M | $29.2M | ||
| Q3 25 | $99.5M | $26.5M | ||
| Q2 25 | $27.3M | $-795.0K | ||
| Q1 25 | $51.0M | $-3.5M | ||
| Q4 24 | $54.0K | $61.8M | ||
| Q3 24 | $6.8M | $-14.8M | ||
| Q2 24 | $13.3M | $-9.8M |
自由现金流NUTXRBBN
| Q1 26 | — | — | ||
| Q4 25 | $69.0M | $27.3M | ||
| Q3 25 | $99.2M | $21.0M | ||
| Q2 25 | $26.5M | $-6.5M | ||
| Q1 25 | $50.9M | $-15.7M | ||
| Q4 24 | $-341.0K | $53.8M | ||
| Q3 24 | $6.2M | $-23.7M | ||
| Q2 24 | $12.7M | $-12.9M |
自由现金流率NUTXRBBN
| Q1 26 | — | — | ||
| Q4 25 | 45.5% | 12.0% | ||
| Q3 25 | 37.0% | 9.7% | ||
| Q2 25 | 10.9% | -2.9% | ||
| Q1 25 | 24.0% | -8.7% | ||
| Q4 24 | -0.1% | 21.4% | ||
| Q3 24 | 7.8% | -11.3% | ||
| Q2 24 | 16.7% | -6.7% |
资本支出强度NUTXRBBN
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 0.9% | ||
| Q3 25 | 0.1% | 2.6% | ||
| Q2 25 | 0.3% | 2.6% | ||
| Q1 25 | 0.0% | 6.7% | ||
| Q4 24 | 0.2% | 3.2% | ||
| Q3 24 | 0.8% | 4.2% | ||
| Q2 24 | 0.7% | 1.6% |
现金转化率NUTXRBBN
| Q1 26 | — | — | ||
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
